Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

7 Dec 2017 07:00

RNS Number : 6235Y
S & U PLC
07 December 2017
 

7th December 2017

 

 

S&U plc

("S&U"or "the Group")

 

 

TRADING STATEMENT

 

S&U plc, the specialist hire purchase motor finance and property bridging lender, announces its trading update for the period from 1st August to 6th December 2017 and is pleased to continue trading in line with expectations.

 

Motor Finance

Advantage Finance, our specialist motor finance provider based in Grimsby continues its excellent progress. Despite recent downgraded forecasts for the UK economy, Advantage applications for finance have been very good. This has enabled Advantage both to maintain this year's rate of transactions growth and to revise, refine and further strengthen its under-writing model.

 

As a result, live customer numbers have grown to 53,000 from 49,000 at the half year; this means that net customer receivables now stand at over £240m for the first time, compared to nearly £227m in July.

 

Monthly collections and overall credit quality remain good. Whilst rolling 12 months impairment to revenue has increased slightly to 23.4%, this continues to be primarily due to overall portfolio product mix.

 

Whilst the above underwriting refinements have seen a slight reduction in loan approvals, appropriate in a more uncertain economic climate, the introduction of Advantage's new e-signature Dealfo system has been well received by both customers and brokers and has led to an improvement in the approval-transaction rate.

 

Property Bridging Finance

Our pilot bridging operation, Aspen Finance, has made significant progress and increased its loan book to £9m from £2m in July. Margins and LTV are within budget and very early repayment experience is good.

 

Aspen's growing reputation for efficient, consistent and prompt service to the broking community, augers well for a successful trial period concluding in H2 2018.

 

Funding

Having obtained further funding of £20m during the period, the Group now has total available committed facilities of £115m, sufficient to accommodate current growth at both Advantage and Aspen. Further facilities will be arranged as required.

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"Whatever the current political uncertainty, particularly over Brexit, and despite a forecast slowing economy, demand for S&U's products remains very robust. Our selective lending and continuous refinement of our under-writing underpin our debt quality and produce steady sustainable growth.

 

"I am pleased to see this seemingly becoming more widely recognised within the investing community; we will continue our high standards of responsible lending and the excellent performance which results from this."

 

For further information, please contact:

 

S&U plc: www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Peel Hunt

Adrian Trimmings/Rishi Shah 020 7418 8900

 

Media and Investor Relations

Ged Brumby 020 3047 2527

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIBDDRBGBGRL
Date   Source Headline
13th Apr 20174:24 pmRNSAnnual Financial Report
28th Mar 20177:00 amRNSFinal Results
10th Feb 20177:00 amRNSTrading Statement
19th Dec 20163:42 pmRNSDirector/PDMR Shareholding
14th Dec 201610:40 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSTrading Statement
6th Dec 201611:26 amRNSDirector/PDMR Shareholding
29th Nov 201612:40 pmRNSDirector/PDMR Shareholdings
29th Nov 201610:47 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20163:36 pmRNSExercise and Sale of Options
19th Oct 201612:43 pmRNSDirector/PDMR Shareholding
27th Sep 20167:00 amRNSHalf-year Report
5th Aug 20167:00 amRNSTrading Statement
26th Jul 20164:41 pmRNSSecond Price Monitoring Extn
26th Jul 20164:35 pmRNSPrice Monitoring Extension
8th Jul 201611:30 amRNSDirector/PDMR Shareholding
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20167:00 amRNSAnalyst Day 2016
9th Jun 201611:22 amRNSExercise and Sale of Options
27th May 20163:25 pmRNSDirector/PDMR Shareholding
26th May 20163:20 pmRNSBlock Listing Six Monthly Return
17th May 201612:41 pmRNSResult of AGM
17th May 20167:00 amRNSAGM Statement & Trading Update
3rd May 20169:13 amRNSTotal Voting Rights
15th Apr 20162:49 pmRNSAnnual Report and Accounts
13th Apr 20162:29 pmRNSExercise & Sale of Options/ Directors Shareholding
6th Apr 20164:49 pmRNSDirector/PDMR Shareholding
4th Apr 201612:38 pmRNSBlock Listing Application
22nd Mar 20167:00 amRNSAppointment of Non-Executive Director
22nd Mar 20167:00 amRNSPreliminary Results for Year Ended 31 January 2016
12th Feb 20167:00 amRNSTrading Update
15th Jan 20165:13 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSRe: Options/ Directors' shareholding
11th Dec 20153:35 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSTrading Statement
23rd Nov 20157:00 amRNSBlocklisting Six Monthly Return
28th Sep 20155:33 pmRNSRe: Options/ Directors' Shareholding
22nd Sep 20157:00 amRNSHalf Yearly Report
5th Aug 20157:00 amRNSTrading Statement
4th Aug 20151:18 pmRNSCompletion of Disposal and Director Shareholding
3rd Aug 201512:00 pmRNSResult of General Meeting
9th Jul 20155:16 pmRNSPosting of Circular
7th Jul 201512:45 pmRNSDisposal
26th May 201512:54 pmRNSBlock Listing Application
26th May 201512:51 pmRNSBlocklisting Interim Review
21st May 20152:23 pmRNSAGM Statement
21st May 20157:00 amRNSInterim Management Statement
17th Apr 20157:00 amRNSAnnual Financial Report
1st Apr 201512:58 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.